Authors:
Topol, EJ
Califf, RM
Van de Werf, F
Willerson, JT
Booth, J
White, H
Clayman, M
Deckelbaum, L
Lincoff, AM
Ohman, EM
Bates, E
Gibler, WB
Hochman, J
Kleiman, N
Grinfeld, L
Aylward, P
Armstrong, PW
Heikkila, J
Vahanian, A
Steg, G
Bode, C
Adgy, AAJ
Guetta, V
Ardissino, D
Savonitto, S
Bar, F
Simoons, M
Kontny, F
White, H
Sadowski, Z
Seabra-Gomes, R
Dalby, A
Betriu, A
Swahn, E
Wilcox, R
Frye, RL
Bertrand, ME
DeMets, D
Fox, KKA
Fuster, V
Lee, KL
McCarthy, C
Waller, M
Scherer, J
van de Kerkhove, A
Kukulewicz, L
Booth, JE
Del Valle, M
Hibert, D
Brannon, D
Citation: Ej. Topol et al., Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised trial, LANCET, 357(9272), 2001, pp. 1905-1914
Authors:
Alonso, G
Petranovskii, V
Del Valle, M
Cruz-Reyes, J
Licea-Claverie, A
Fuentes, S
Citation: G. Alonso et al., Preparation of WS2 catalysts by in situ decomposition of tetraalkylammonium thiotungstates, APP CATAL A, 197(1), 2000, pp. 87-97